×

Healthcare

USD Analytics healthcare data solutions deliver information, analytics, and solutions for the world’s major medical device, pharmaceutical companies, financial markets, and governments. The company leverages its vast databases and industry expertise to present in-depth and up-to-date analyses of healthcare industries. The solution enables users to make efficient and informed decisions across the market. The Global Healthcare markets service presents an analysis of 60 countries with an updated outlook for the pharmaceutical industry. The reports in the service are updated every month and present healthcare expenditure, pharmaceutical sales, pharmaceutical goods trade balance, population forecasts, life expectancy, Consumer Price Inflation, GDP forecast, regulatory analysis, and company profiles. The Pipeline, Epidemiology, and Disease Market Outlook service presents disease pipeline reviews, clinical trial analysis, epidemiology reports, and disease market outlook for over 300 conditions. In addition, Analysis of marketed drugs, upcoming drug candidates, and other information is included in the research solutions. Further, the market size outlook and competitive analysis of medical devices, Healthcare IT, Analytics and Instrumentation, and the Biotechnology industry outlook are analyzed.

Healthcare
Report Name

Medical Polyoxymethylene Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Homopolymer POM, Copolymer POM), By Application (Dialysis Machine, Handles for Surgical Instruments, Inhalers, Insulin Pen, Medical Trays, Pharmaceutical Closures, Others), Countries and Companies Report

Global Medical Polyoxymethylene is forecast to reach $205.9 Million in 2030 from $143.5 Million in 2024, registering a CAGR of 6.2%

Published On: November, 2024  |   Report Code: USD00027166  |   No. of Pages: 206

Cellulite Treatment Market Size, Share, Trends, Growth Outlook and Opportunities to 2030-by Procedure (Non-invasive, Minimally Invasive, Topical), by Cellulite (Soft Cellulite, Hard Cellulite, Edematous Cellulite), by End-Use (Hospitals, Clinics & Beauty Centers), and Companies Report

Cellulite Treatment Market is projected to reach at a high CAGR during the period of 2023-2030. Geographically, the market is classified into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Published On: November, 2024  |   Report Code: USD0002955  |   No. of Pages: 203

Cell and Gene Therapy Clinical Trials Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication (Oncology, Cardiology, CNS, Musculoskeletal, Infectious diseases, Dermatology, Endocrine, metabolic, genetic, Immunology & inflammation, Ophthalmology, Hematology, Gastroenterology, Others), Countries and Companies Report

Cell and Gene Therapy Clinical Trials Market is projected to register a 17.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD0003061  |   No. of Pages: 195

Dry Eye Treatment Devices Market Size, Share, Trends, Growth Outlook and Opportunities to 2030-by Technology (Broadband Light, Intense Pulsed Light, Meibomian Gland Expression, Combination), by End-Use (Hospitals, Ophthalmic Clinics, Others), and Companies Report

Dry Eye Treatment Devices Market is projected to reach at a 7.1 CAGR during the period of 2023-2030. Geographically, the market is classified into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Published On: November, 2024  |   Report Code: USD0002922  |   No. of Pages: 196

Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Share, Trends, Growth Outlook and Opportunities to 2030-by Drugs (Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies and Cancer Vaccines, Others), by Service (Target Identification and Validation, Lead Screening and Characterization, Cell-based Assays), by Therapeutic Area (Lung, Breast, Colorectal, Melanoma, Prostate, Head and Neck, Ovarian, Pancreatic), and Companies Report

Cancer Immunotherapy Drug Discovery Outsourcing Market is projected to reach at a high CAGR during the period of 2023-2030. Geographically, the market is classified into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Published On: November, 2024  |   Report Code: USD0002989  |   No. of Pages: 195

Multiple Myeloma Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug (Chemotherapy, Protease Inhibitors, Monoclonal Antibody, Others), By Disease (Active Multiple Myeloma, Smoldering Multiple Myeloma), By End-User (Hospitals, Clinics, Others), Countries and Companies Report

Multiple Myeloma is projected to register a 6.8% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: November, 2024  |   Report Code: USD0007424  |   No. of Pages: 205

Cryoglobulinemia Treatment Market Size, Share, Trends, Growth Outlook and Opportunities to 2030- By Type (Type I Cryoglobulinemia, Mixed Cryoglobulinemia (Type II & Type III), Essential Cryoglobulinemia, Secondary Cryoglobulinemia) By Treatment Type ( Drugs, And Therapy) And By End User ( Hospitals, Specialty Clinics, And Ambulatory Surgical Centres) and by Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Cryoglobulinemia Treatment Market is projected to reach at a high CAGR during the period of 2023-2030. Geographically, the market is classified into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Published On: November, 2024  |   Report Code: USD0007426  |   No. of Pages: 200

Cholesteatoma Treatment Market Size, Share, Trends, Growth Outlook and Opportunities to 2030- by treatment (surgery, mastoidectomy, tympanoplasty, medicines, antibiotics, others) and by end-user ( hospitals, clinics, and others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Cholesteatoma Treatment Market is projected to reach at a high CAGR during the period of 2023-2030. Geographically, the market is classified into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Published On: November, 2024  |   Report Code: USD0007414  |   No. of Pages: 200

Polycystic Kidney Disease Market Segmented By Type (Autosomal Dominant Polycystic Kidney Disease, Autosomal Recessive Polycystic Kidney Disease, Others), Treatment (Medication, Surgery, Others), Diagnosis (Ultrasound, CT Scan, MRI Scan), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others)

Polycystic Kidney Disease Market Size is projected to reach USD YY billion by 2030. The market classified into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa,

Published On: November, 2024  |   Report Code: USD000209  |   No. of Pages: 150